Database

Startups

Main Industry
Health Care
Founded Year
2011
Unified Business No.
53503311
Status
Active
Number of Employees
0
Total Paid-in Capital
10,000,000 (NT$)
Location of Company
Taiwan , Yunlin County
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.

Similar Companies

Ori-Genic Biotech Corporation

Pilatus Biosciences offers a unique opportunity to invest early at an attractive valuation. Our innovative therapies are already drawing strong interest from global pharmaceutical leaders, positioning us for high-value licensing deals or early M&A exits. In today’s selective market, Pilatus stands out through scientific innovation, capital efficiency, and a clear path to value creation.


Investment Highlights
01. About Us
Pilatus Biosciences is a preclinical-stage biotech company pioneering first-in-class biologics targeting metabolic checkpoints to reprogram the tumor microenvironment (TME)
02. Novel Science
Differentiated Immunometabolism approach targeting growing Cancer Immunotherapy and Metabolic Disease market
03. Lead Pipeline: PLT012
PLT012, a humanized anti-CD36 antibody, has demonstrated preclinical efficacy and received FDA Orphan Drug Designation for Liver cancers.